ADVANCED SOLID TUMORS, ADULT

Clinical trials for ADVANCED SOLID TUMORS, ADULT explained in plain language.

Never miss a new study

Get alerted when new ADVANCED SOLID TUMORS, ADULT trials appear

Sign up with your email to follow new studies for ADVANCED SOLID TUMORS, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New targeted drug trial launches for Hard-to-Treat cancers

Disease control Not yet recruiting

This early-stage study is testing a new targeted drug called CGT6297 in adults with advanced solid tumors that have a specific genetic change called a PIK3CA mutation. The main goals are to find a safe dose and see if the drug shows early signs of helping to shrink tumors. The st…

Matched conditions: ADVANCED SOLID TUMORS, ADULT

Phase: PHASE1 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ADVANCED SOLID TUMORS, ADULT

Get alerted when new ADVANCED SOLID TUMORS, ADULT trials appear

New targeted drug trial launches for Hard-to-Treat cancers